Log In
Print this Print this

BAY 87-2243

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionInhibitor of hypoxia-inducible (HIF-1a)
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionHypoxia-inducible factor 1 alpha (HIF-1 alpha) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerAmgen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today